Skip to content

A Digital Non-interventional Atrial Fibrillation (AF) Screening Study With Commercial Pulse Detection Systems

BAYathlon - a Digital Non-interventional AF Screening Study to Identify Commercial Pulse Detection Systems (CPDS) Detecting AF and Sinus Rhythm Parallel to ECG Recording Within Routine Clinical Setting

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02875106
Acronym
BAYathlon
Enrollment
165
Registered
2016-08-23
Start date
2017-11-08
Completion date
2019-05-08
Last updated
2020-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Sinus rhythm

Brief summary

The primary objective in this study is to identify commercial pulse detection systems (CPDS) parallel to electrocardiogram (ECG) recording within routine clinical setting, which are able to detect atrial fibrillation or sinus rhythm of screened patients.

Interventions

DEVICE12-point-ECG

routine recording will be 300 seconds

routine recording will be 300 seconds

DEVICE360° eMotion FAROS SET + Belt

routine recording will be 300 seconds

DEVICEAdidas Micoach smart run

routine recording will be 300 seconds

DEVICETomTom Runner Cardio HRM

routine recording will be 300 seconds

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult female and male patients for whom the decision to record an ECG was made as per investigator's routine treatment practice * Patient able and willing to provide signed informed consent

Exclusion criteria

* Patients with any comorbidities or abnormalities of heart function or rhythm, which might, in the opinion of the investigator, interfere with the evaluation of study data * Patients participating in an investigational program with interventions outside of routine clinical practice

Design outcomes

Primary

MeasureTime frameDescription
The rate of correctly detected atrial fibrillation signals by CPDS in reference to ECG (sensitivity of CPDS).120 secondsThis will be calculated as proportion of patients with atrial fibrillation diagnosed by CPDS record out of the total number of patients diagnosed with atrial fibrillation by ECG record (for patients with diagnosis for both recordings available).

Secondary

MeasureTime frameDescription
The rate of correctly detected sinus rhythm signals by CPDS in reference to ECG (sensitivity of CPDS).120 secondsThis will be calculated as proportion of patients with sinus rhythm diagnosed by CPDS record out of the total number of patients diagnosed with sinus rhythm by ECG record (for patients with diagnosis for both recordings available).
The rate of correctly detected AF of the applied algorithm of the ECG-data in reference to the primary diagnosis of the investigator using the ECG-graph (sensitivity of algorithm).120 secondsThis will be calculated as proportion of AF patients detected by the applied algorithm compared with proportion of AF patients diagnosed by the investigator, both based on ECG records.
The rate of correctly detected atrial fibrillation signals by CPDS in reference to ECG (sensitivity of CPDS).60 seconds, 180 seconds, 240 seconds, 300 secondsThis will be a sensitivity analysis of derived sensitivities of CPDS in different time frames, calculated as proportion of patients with sinus rhythm diagnosed by CPDS record out of the total number of patients diagnosed with sinus rhythm by ECG record (for patients with diagnosis for both recordings available).

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026